Trulieve Cannabis Corp Stock Price To Earning
| TCNNF Stock | USD 6.07 0.08 1.34% |
Trulieve Cannabis Corp fundamentals help investors to digest information that contributes to Trulieve Cannabis' financial success or failures. It also enables traders to predict the movement of Trulieve OTC Stock. The fundamental analysis module provides a way to measure Trulieve Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Trulieve Cannabis otc stock.
Trulieve |
Trulieve Cannabis Corp OTC Stock Price To Earning Analysis
Trulieve Cannabis' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Trulieve Cannabis Price To Earning | 23.96 X |
Most of Trulieve Cannabis' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Trulieve Cannabis Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Trulieve Cannabis Corp has a Price To Earning of 23.96 times. This is 7.28% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to earning for all United States stocks is 16.57% higher than that of the company.
Trulieve Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trulieve Cannabis' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Trulieve Cannabis could also be used in its relative valuation, which is a method of valuing Trulieve Cannabis by comparing valuation metrics of similar companies.Trulieve Cannabis is currently under evaluation in price to earning category among its peers.
Trulieve Cannabis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Trulieve Cannabis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Trulieve Cannabis' managers, analysts, and investors.Environmental | Governance | Social |
Trulieve Fundamentals
| Return On Equity | -0.14 | |||
| Return On Asset | 0.0479 | |||
| Profit Margin | (0.19) % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 2.48 B | |||
| Shares Outstanding | 159.64 M | |||
| Shares Owned By Insiders | 8.76 % | |||
| Shares Owned By Institutions | 12.51 % | |||
| Price To Earning | 23.96 X | |||
| Price To Book | 0.83 X | |||
| Price To Sales | 1.26 X | |||
| Revenue | 938.38 M | |||
| Gross Profit | 607.32 M | |||
| EBITDA | 276.51 M | |||
| Net Income | 18.03 M | |||
| Cash And Equivalents | 114.47 M | |||
| Cash Per Share | 0.62 X | |||
| Total Debt | 469.38 M | |||
| Debt To Equity | 0.47 % | |||
| Current Ratio | 3.28 X | |||
| Book Value Per Share | 10.82 X | |||
| Cash Flow From Operations | 12.9 M | |||
| Earnings Per Share | (0.29) X | |||
| Target Price | 22.04 | |||
| Number Of Employees | 8 K | |||
| Beta | 1.72 | |||
| Market Capitalization | 1.15 B | |||
| Total Asset | 3.41 B | |||
| Z Score | 1.2 | |||
| Net Asset | 3.41 B |
About Trulieve Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Trulieve Cannabis Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trulieve Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trulieve Cannabis Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Trulieve OTC Stock
Trulieve Cannabis financial ratios help investors to determine whether Trulieve OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Trulieve with respect to the benefits of owning Trulieve Cannabis security.